Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Suzhou Zelgen Biopharmaceuticals Co., Ltd. - Enterprise Valueverified

688266.SS

Price:

$120.4

Market Cap:

$31.87B

Suzhou Zelgen Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China. The company offers donafenib tablets for hepatocellular carcinoma and iodine-refractory differentiated thyroid cancer; recombinant human thrombin for hemostasis; and jacktinib tablets for intermediate and high-risk myelofibrosis. It also develops drug candidates in the NDA, Phase III, or registration clinical trial stages, such as gecacitinib hydrochloride tablets for severe alopecia areata, moderate to severe atopic dermatitis, ankylosing spondylitis, ruxolitinib-intolerant and relapsed/refractor...[Read more]

Industry

Biotechnology

IPO Date

2020-01-23

Stock Exchange

SHH

Ticker

688266.SS

The Enterprise Value as of August 2026 (TTM) for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) is 30.63B

According to Suzhou Zelgen Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 30.63B. This represents a change of 13.45% compared to the average of 27.00B of the last 4 quarters.

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) Historical Enterprise Value (quarterly & annually)

How has 688266.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Suzhou Zelgen Biopharmaceuticals Co., Ltd. over the last ten years is 40.31B. The current 30.63B Enterprise Value has changed 7.50% with respect to the historical average. Over the past ten years (40 quarters), 688266.SS's Enterprise Value was at its highest in in the December 2018 quarter at 301.39B. The Enterprise Value was at its lowest in in the September 2022 quarter at 7.74B.

Quarterly (TTM)
Annual

Average

40.31B

Median

13.30B

Minimum

-17025414.00

Maximum

301.39B

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Suzhou Zelgen Biopharmaceuticals Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 53.03%

Maximum Annual Enterprise Value = 301.39B

Minimum Annual Increase = -3049159.08%

Minimum Annual Enterprise Value = -17025414.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202523.54B53.03%
202415.39B24.34%
202312.37B27.10%
20229.74B-26.21%
202113.19B-6.32%
202014.08B5.11%
201913.40B-95.55%
2018301.39B-3049159.08%
2017-9884526.00-41.94%

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) Average Enterprise Value

How has 688266.SS Enterprise Value performed in the past?

The current Enterprise Value of Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

17.10B

5-year avg

14.85B

10-year avg

40.31B

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) Enterprise Value vs. Peers

How is 688266.SS’s Enterprise Value compared to its peers?

Suzhou Zelgen Biopharmaceuticals Co., Ltd.’s Enterprise Value is greater than Shijiazhuang Yiling Pharmaceutical Co., Ltd. (27.57B), greater than Hualan Biological Engineering Inc. (23.35B), greater than Xiamen Amoytop Biotech Co., Ltd. (24.07B), greater than Sinocelltech Group Limited (21.02B), less than Asymchem Laboratories (Tianjin) Co., Ltd. (50.51B), greater than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (11.34B), less than Zhejiang Huahai Pharmaceutical Co., Ltd. (33.56B), less than Shanghai Junshi Biosciences Co., Ltd. (42.69B), greater than Kangmei Pharmaceutical Co., Ltd. (18.42B), greater than DaShenLin Pharmaceutical Group Co., Ltd. (16.12B),

Build a custom stock screener for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Suzhou Zelgen Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Suzhou Zelgen Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Suzhou Zelgen Biopharmaceuticals Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?

What is the 3-year average Enterprise Value for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?

What is the 5-year average Enterprise Value for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?

How does the current Enterprise Value for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) compare to its historical average?